会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Aminoacid derivatives of cephalosporin compounds
    • 头孢菌素化合物的氨基酸衍生物
    • US4311699A
    • 1982-01-19
    • US112656
    • 1980-01-31
    • Theodore H. HaskellThomas F. MichJoseph P. SanchezDietrich Schweiss
    • Theodore H. HaskellThomas F. MichJoseph P. SanchezDietrich Schweiss
    • C07D239/36C07D501/24C07D521/00A61K31/545C07D501/34C07D501/56
    • C07D239/36C07D231/12C07D233/56C07D249/08
    • Novel organic amide compounds which are N-[2-[(acylaminoacylamino or aminoacylamino)phenyl]-4-hydroxy-5-pyrimidinylcarbonyl]cephalosporin compounds having broad spectrum antibacterial utility are provided by (a) reacting the free amino acid of the appropriate cephalosporin or the acid salt or silylated derivative or complex thereof with a reactive derivative of the corresponding N-2-[(acylaminoacylamino or aminoacylamino)phenyl]-4-hydroxy-5-pyrimidine carboxylic acid or (b) reacting the free amino acid 7-aminocephalosporanic acid or a related compound or the acid salt or silylated derivative thereof with a reactive derivative of the corresponding D-N-[2-[(acylaminoacylamino or aminoacylamino)phenyl]-4-hydroxy-5-pyrimidinylcarbonyl]-2-substituted glycine. Pharmaceutical compositions containing said compounds and methods for treating infections using said compositions are also disclosed.
    • 通过(a)使适当头孢菌素的游离氨基酸反应,得到具有广谱抗菌效用的N- [2 - [(酰氨基酰氨基或氨基酰氨基)苯基] -4-羟基-5-嘧啶基羰基]头孢菌素的新型有机酰胺化合物 或其相应的N-2 - [(酰氨基酰基氨基或氨酰基氨基)苯基] -4-羟基-5-嘧啶羧酸的反应性衍生物的酸式盐或甲硅烷基化衍生物或其配合物,或(b)使游离氨基酸7- 氨基头孢烷酸或相关化合物或其酸盐或甲硅烷基化衍生物与相应的DN- [2 - [(酰氨基酰基氨基或氨酰基氨基)苯基] -4-羟基-5-嘧啶基羰基] -2-取代的甘氨酸的反应性衍生物。 还公开了含有所述化合物的药物组合物和使用所述组合物治疗感染的方法。
    • 9. 发明授权
    • Cephalosporins
    • 头孢菌素
    • US4404201A
    • 1983-09-13
    • US321021
    • 1981-11-13
    • Theodore H. HaskellMarland P. Hutt
    • Theodore H. HaskellMarland P. Hutt
    • C07D215/54C07D215/56C07D401/06C07D401/12C07D401/14C07D501/34C07D501/36A61K31/545
    • C07D215/56C07D215/54C07D401/06C07D401/12C07D401/14
    • Novel organic amide compounds which are N-[[(acylaminoacylamino or aminoacylamino)]-dihydro-oxo-3-quinolinylcarbonyl]cephalosporin compounds having broad spectrum antibacterial utility are provided by (a) reacting the free amino acid of the appropriate cephalosporin or the acid addition salt or silylated derivative or complex thereof with a reactive derivative of the corresponding (acylaminoacylamino or aminoacylamino)dihydro-oxo-3-quinolinecarboxylic acid or (b) reacting the free amino acid 7-aminocephalosporanic acid or a related compound or the acid salt or silylated derivative thereof with a reactive derivative of the corresponding D-N-[(acylaminoacylamino or aminoacylamino)dihydro-oxo-3-quinolinylcarbonyl]-2-substituted glycine. Pharmaceutical compositions containing said compounds and methods for treating infections using said compositions are also disclosed.
    • 通过(a)使适当的头孢菌素或酸的游离氨基酸反应,得到具有广谱抗菌效用的N - [[(酰氨基酰氨基或氨基酰氨基)] - 二氢 - 氧代-3-喹啉基羰基]头孢菌素化合物 加成盐或甲硅烷基化的衍生物或其配合物与相应的(酰基氨基酰基氨基或氨酰基氨基)二氢 - 氧代-3-喹啉羧酸的反应性衍生物或(b)使游离氨基酸7-氨基头孢烷酸或相关化合物或酸盐或 甲硅烷基化衍生物与相应的DN - [(酰氨基酰氨基或氨酰氨基)二氢 - 氧代-3-喹啉基羰基] -2-取代的甘氨酸的反应性衍生物。 还公开了含有所述化合物的药物组合物和使用所述组合物治疗感染的方法。